Thrombotic thrombocytopenic purpura: Description and analysis of 23 cases treated in Chile between 2017 and 2022

Introduction Since the first description of Thrombotic Thrombocytopenic Purpura, caused by a severe deficiency of ADAMTS13, plasma exchange and immunosuppression have become standard treatments, allowing to decrease its high mortality rate. Prospective records of Thrombotic Thrombocytopenic Purpura...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniel Cathalifaud, Jean-Paul Manríquez, Benjamín Rodríguez, Gonzalo Eymin, Benjamín Sanfuentes, Joel Castellano, Andrés Valenzuela
Format: Article
Language:English
Published: Medwave Estudios Limitada 2025-07-01
Series:Medwave
Subjects:
Online Access:https://www.medwave.cl/investigacion/estudios/3002.html
Tags: Add Tag
No Tags, Be the first to tag this record!